Human Genome Sciences Announces Positive Interim Results of Phase ... - PharmaLive.com (press release)
February 28, 2007| Human Genome Sciences Announces Positive Interim Results of Phase ... PharmaLive.com (press release), PA - The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. ... |
Denenberg: Answering Questions On Avoiding Phthalates, Shrimp's ... - Evening Bulletin
February 28, 2007| Denenberg: Answering Questions On Avoiding Phthalates, Shrimp's ... Evening Bulletin, PA - The more common forms are osteoarthritis, rheumatoid arthritis, gout, system lupus erythematosus, polymyalgia rheumatica, ankylosing spondylitis, ... |
Accentia Biopharmaceuticals acquires worldwide exclusive license ... - EurekAlert (press release)
February 28, 2007| Accentia Biopharmaceuticals acquires worldwide exclusive license ... EurekAlert (press release), DC - Investigators have reported favorable case experience with refractory scleroderma, acquired pemphigus, rheumatoid arthritis, and Crohn's Disease. ... Accentia Biopharmaceuticals acquires worldwide exclusive license ... |
UCB Full-Year 2006 Financial Results - PharmaLive.com (press release)
February 28, 2007| UCB Full-Year 2006 Financial Results PharmaLive.com (press release), PA - Cimzia™ in the treatment of rheumatoid arthritis showed positive Phase III results demonstrating significant improvement in signs and symptoms and ... |
Accentia Biopharmaceuticals Acquires Worldwide Exclusive License ... - PharmaLive.com (press release)
February 28, 2007| Accentia Biopharmaceuticals Acquires Worldwide Exclusive License ... PharmaLive.com (press release), PA - Investigators have reported favorable case experience with refractory scleroderma, acquired pemphigus, rheumatoid arthritis, and Crohn's Disease. ... Accentia Biopharmaceuticals (ABPI) Acquires Worldwide Rights for ... |
Appearance concerns related to depression in patients with ... - eMaxHealth.com
February 28, 2007 SpiritIndia | Appearance concerns related to depression in patients with ... eMaxHealth.com, NC - Patients with rheumatic disease can experience physical deformities, especially of the hands and feet in the case of rheumatoid arthritis (RA), ... Psychological Distress and Rheumatic Diseases |
Relationship between appearance and psychological distress in ... - News-Medical.net
February 28, 2007SpiritIndia | Relationship between appearance and psychological distress in ... News-Medical.net, Australia - Patients with rheumatic disease can experience physical deformities, especially of the hands and feet in the case of rheumatoid arthritis (RA), ... Psychological Distress and Rheumatic Diseases |
FDA approves new Crohn's disease treatment - ImediNews
February 28, 2007| FDA approves new Crohn's disease treatment ImediNews, Georgia - Humira, manufactured by Abbott Laboratories, was previously approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing ... |
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment Of ... - Medical News Today (press release)
February 28, 2007 SpiritIndia | HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment Of ... Medical News Today (press release), UK - The safety profile of HUMIRA in the Crohn's clinical trials was similar to that seen in HUMIRA clinical trials for rheumatoid arthritis (RA). ... Humira OK’d to treat Crohn’s |